<DOC>
	<DOCNO>NCT00202241</DOCNO>
	<brief_summary>The main aim study investigate combine effect use anabolic steroid protease inhibitor fat metabolism body composition People Living HIV/AIDS . We seek answer follow question : 1 ) Are significant difference serum blood lipid , lipodystrophy , person HIV take antiretroviral therapy anabolic steroid versus antiretroviral therapy alone ?</brief_summary>
	<brief_title>The Effects Anabolic Steroids Protease Inhibitors People Living With HIV/AIDS</brief_title>
	<detailed_description>Changes body composition waste constant concern people live HIV/AIDS . Testosterone derivatives , anabolic steroid ( AS ) use person HIV/AIDS ( PHA 's ) treat AIDs relate waste syndrome also bodybuilding purpose . study show AS positive impact weight well-being HIV seropositive individual . It show protease inhibitor ( PI 's ) combination antiretroviral HIV therapy associate symmetrical loss subcutaneous fat body surface ( lipodystrophy ) PHAs . The mechanism lipodystrophy well understood . However , associate hyperlipidemia contribute central fat deposition , insulin resistance , , type 2 diabetes . As well , increase visceral abdominal fat loss fat inthe arm , legs face , increased level serum lipids reported.The health effect anabolic steroid therapy couple PIs examine . This study observational study investigate phenomenon lipodystrophy HIV population already expose AS PIs . A prospective observational design employ , two group recruit . One group take AS PI 's , take PIs . The group ask complete Quality Life nutrition physical activity questionnaire . Serum blood lipid characteristic compare , body composition determine use MRIs , BIA 's skinfold measurement .</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Lipodystrophy</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>document HIV seropositive status 18 year age old combination antiretroviral therapy least three month able comply study procedure protocol sign informed consent acute opportunistic infection baseline use serum lipid lower drug use serum sugar control drug evidence drug alcohol use may interfere study participation recent illness associate weight loss great equal 10lbs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>testosterone</keyword>
	<keyword>anabolic steroid</keyword>
	<keyword>body composition</keyword>
	<keyword>lipodystrophy</keyword>
	<keyword>MRI</keyword>
	<keyword>BIA</keyword>
	<keyword>skinfold measurement</keyword>
	<keyword>protease inhibitor</keyword>
</DOC>